Potential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageing.
Henman, Martin C
AffiliationSchool of Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland. firstname.lastname@example.org.
MetadataShow full item record
CitationCousins G et al. Potential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageing. BMC Geriatr. 2014: 14:57
AbstractOlder adults are susceptible to adverse effects from the concomitant use of prescription medications and alcohol. This study estimates the prevalence of exposure to alcohol interactive (AI) medications and concomitant alcohol use by therapeutic class in a large, nationally representative sample of older adults.
Cross-sectional analysis of a population based sample of older Irish adults aged ≥60 years using data from The Irish Longitudinal Study on Ageing (TILDA) (N = 3,815). AI medications were identified using Stockley's Drug Interactions, the British National Formulary and the Irish Medicines Formulary. An in-home inventory of medications was used to characterise AI drug exposure by therapeutic class. Self-reported alcohol use was classified as non-drinker, light/moderate and heavy drinking. Comorbidities known to be exacerbated by alcohol were also recorded (diabetes mellitus, hypertension, peptic ulcer disease, liver disease, depression, gout or breast cancer), as well as sociodemographic and health factors.
Seventy-two per cent of participants were exposed to AI medications, with greatest exposure to cardiovascular and CNS agents. Overall, 60% of participants exposed to AI medications reported concomitant alcohol use, compared with 69.5% of non-AI exposed people (p < 0.001). Almost 28% of those reporting anti-histamine use were identified as heavy drinkers. Similarly almost one in five, combined heavy drinking with anti-coagulants/anti-platelets and cardiovascular agents, with 16% combining heavy drinking with CNS agents. Multinomial logistic regression showed that being male, younger, urban dwelling, with higher levels of education and a history of smoking, were associated with an increased risk for concomitant exposure to alcohol consumption (both light/moderate and heavier) and AI medications. Current smokers and people with increasing co-morbidities were also at greatest risk for heavy drinking in combination with AI medications.
The concurrent use of alcohol with AI medications, or with conditions known to be exacerbated by alcohol, is common among older Irish adults. Prescribers should be aware of potential interactions, and screen patients for alcohol use and provide warnings to minimize patient risk.
- Potential for alcohol and prescription drug interactions in older people.
- Authors: Pringle KE, Ahern FM, Heller DA, Gold CH, Brown TV
- Issue date: 2005 Nov
- A profile of concurrent alcohol and alcohol-interactive prescription drug use in the US population.
- Authors: Jalbert JJ, Quilliam BJ, Lapane KL
- Issue date: 2008 Sep
- The relationship of tobacco and alcohol use with ageing self-perceptions in older people in Ireland.
- Authors: Villiers-Tuthill A, Copley A, McGee H, Morgan K
- Issue date: 2016 Jul 22
- Concurrent use of alcohol interactive medications and alcohol in older adults: a systematic review of prevalence and associated adverse outcomes.
- Authors: Holton AE, Gallagher P, Fahey T, Cousins G
- Issue date: 2017 Jul 17
- Longitudinal prevalence of potentially serious alcohol-medication interactions in community-dwelling older adults: a prospective cohort study.
- Authors: Holton A, Boland F, Gallagher P, Fahey T, Kenny RA, Cousins G
- Issue date: 2019 Apr